Differential effects of lenalidomide during plasma cell differentiation

Thalidomide, lenalidomide and pomalidomide have greatly improved the outcome of patients with multiple myeloma. However, their effects on plasma cells, the healthy counterpart of myeloma cells, are unknown. Here, we investigated lenalidomide effects on normal human plasma cell generation using an in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Jourdan, Michel, Cren, Maïlys, Schafer, Peter, Robert, Nicolas, Duperray, Christophe, Vincent, Laure, Ceballos, Patrice, Cartron, Guillaume, Rossi, Jean-François, Moreaux, Jérôme, Chopra, Rajesh, Klein, Bernard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053712/
https://ncbi.nlm.nih.gov/pubmed/27057635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8581
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia